F. Nolasco

Treatment of hepatitis C virus infection in kidney transplant recipients: case report.

V. Baptista, I. Aires, F. Nolasco, 2011, Transplantation proceedings.

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

N. Perico, M. Jardine, V. Perkovic, 2023, The Lancet.